Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 432Sesión 2026

Qué cambió entre versiones

8 párrafos cambiaron+7 palabras agregadas−9 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

ENROLLED

2026

Legislature

CS for SB 432, 1st Engrossed

First Engrossed

2026432e12026432er

1 A bill to be entitled

1

2 An act relating to intoxicating substances; providing

1333 párrafos sin cambios

3 a short title; creating s. 569.216, F.S.; prohibiting

4 tobacco or nicotine dealers, or their agents or

5 employees, from possessing, selling, possessing with

6 intent to sell, delivering, or giving, directly or

7 indirectly, nitrous oxide on or from the dealer’s

8 licensed premises; providing criminal penalties;

9 providing applicability; providing construction;

10 requiring the Department of Business and Professional

11 Regulation to adopt rules; amending s. 893.03, F.S.;

12 excepting from the list of Schedule I controlled

13 substances certain xylazine animal drug products

14 approved by the United States Food and Drug

15 Administration and used for certain purposes; amending

16 s. 893.13, F.S.; providing criminal penalties and

17 requiring a mandatory minimum term of imprisonment if

18 a person sells, manufactures, or delivers or possesses

19 with intent to sell, manufacture, or deliver xylazine;

20 amending s. 893.135, F.S.; creating the offense of

21 trafficking in xylazine; providing criminal penalties

22 and requiring a mandatory minimum term of imprisonment

23 and fines based on the quantity of the controlled

24 substance involved in the offense; providing effective

25 dates.

26

27 Be It Enacted by the Legislature of the State of Florida:

28

29 Section 1.

Section 2 of this act may be cited as “Meg’s

30

Law.”

31 Section 2. Section 569.216, Florida Statutes, is created to

32 read:

33

569.216

Prohibition on possessing, selling, delivering, or

34

giving nitrous oxide; penalties; exceptions.—

35

(1)

It is unlawful for any dealer who is licensed or

36

permitted under this chapter, or a dealer’s agent or employee,

37

to possess, sell, possess with intent to sell, deliver, or give,

38

directly or indirectly, nitrous oxide on or from the dealer’s

39

licensed premises. A dealer or a dealer’s agent or employee who

40

violates this subsection commits a felony of the third degree,

41

punishable as provided in s. 775.082, s. 775.083, or s. 775.084.

42

(2)

This section does not apply to a grocery store or

43

supermarket, as licensed or permitted by the Department of

44

Agriculture and Consumer Services, but does apply to a

45

convenience business, as defined by s. 812.171.

46

(3)

This section does not prohibit the possession, sale,

47

delivery, or giving of a finished food product in which nitrous

48

oxide is used solely as a propellant.

49

(4)

The Department of Business and Professional Regulation

50

shall adopt rules regarding the possession, sale, delivery, or

51

giving of nitrous

oxide to prevent the use of nitrous oxide for

52

inducing a condition of intoxication. Such rules may address

53

products containing nitrous oxide and finished food products in

54

which nitrous oxide is used solely as a propellant

.

55 Section 3. Effective July 1, 2026, paragraph (c) of

56 subsection (1) of section 893.03, Florida Statutes, is amended

57 to read:

58 893.03 Standards and schedules.—The substances enumerated

59 in this section are controlled by this chapter. The controlled

60 substances listed or to be listed in Schedules I, II, III, IV,

61 and V are included by whatever official, common, usual,

62 chemical, trade name, or class designated. The provisions of

63 this section shall not be construed to include within any of the

64 schedules contained in this section any excluded drugs listed

65 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded

66 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical

67 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted

68 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt

69 Anabolic Steroid Products.”

70 (1) SCHEDULE I.—A substance in Schedule I has a high

71 potential for abuse and has no currently accepted medical use in

72 treatment in the United States and in its use under medical

73 supervision does not meet accepted safety standards. The

74 following substances are controlled in Schedule I:

75 (c) Unless specifically excepted or unless listed in

76 another schedule, any material, compound, mixture, or

77 preparation that contains any quantity of the following

78 hallucinogenic substances or that contains any of their salts,

79 isomers, including optical, positional, or geometric isomers,

80 homologues, nitrogen-heterocyclic analogs, esters, ethers, and

81 salts of isomers, homologues, nitrogen-heterocyclic analogs,

82 esters, or ethers, if the existence of such salts, isomers, and

83 salts of isomers is possible within the specific chemical

84 designation or class description:

85 1. Alpha-Ethyltryptamine.

86 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2

87 oxazoline).

88 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).

89 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).

90 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

91 6. Bufotenine.

92 7. Cannabis.

93 8. Cathinone.

94 9. DET (Diethyltryptamine).

95 10. 2,5-Dimethoxyamphetamine.

96 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).

97 12. DMT (Dimethyltryptamine).

98 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine

99 analog of phencyclidine).

100 14. JB-318 (N-Ethyl-3-piperidyl benzilate).

101 15. N-Ethylamphetamine.

102 16. Fenethylline.

103 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.

104 18. Ibogaine.

105 19. LSD (Lysergic acid diethylamide).

106 20. Mescaline.

107 21. Methcathinone.

108 22. 5-Methoxy-3,4-methylenedioxyamphetamine.

109 23. PMA (4-Methoxyamphetamine).

110 24. PMMA (4-Methoxymethamphetamine).

111 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).

112 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

113 27. MDA (3,4-Methylenedioxyamphetamine).

114 28. JB-336 (N-Methyl-3-piperidyl benzilate).

115 29. N,N-Dimethylamphetamine.

116 30. Parahexyl.

117 31. Peyote.

118 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine

119 analog of phencyclidine).

120 33. Psilocybin.

121 34. Psilocyn.

122 35.

Salvia divinorum

, except for any drug product approved

123 by the United States Food and Drug Administration which contains

124

Salvia divinorum

or its isomers, esters, ethers, salts, and

125 salts of isomers, esters, and ethers, if the existence of such

126 isomers, esters, ethers, and salts is possible within the

127 specific chemical designation.

128 36. Salvinorin A, except for any drug product approved by

129 the United States Food and Drug Administration which contains

130 Salvinorin A or its isomers, esters, ethers, salts, and salts of

131 isomers, esters, and ethers, if the existence of such isomers,

132 esters, ethers, and salts is possible within the specific

133 chemical designation.

134 37. Xylazine

, except for a xylazine animal drug product

135

approved by the United States Food and Drug Administration and

136

the use of which conforms to the approved application or is

137

authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,

138

importation, distribution, prescribing, or sale of xylazine for

139

human use is not subject to this exception

.

140 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)

141 (Thiophene analog of phencyclidine).

142 39. 3,4,5-Trimethoxyamphetamine.

143 40. Methylone (3,4-Methylenedioxymethcathinone).

144 41. MDPV (3,4-Methylenedioxypyrovalerone).

145 42. Methylmethcathinone.

146 43. Methoxymethcathinone.

147 44. Fluoromethcathinone.

148 45. Methylethcathinone.

149 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2

150 yl)phenol) and its dimethyloctyl (C8) homologue.

151 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2

152 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].

153 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

154 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

155 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1

156 naphthoyl)indole).

157 51. BZP (Benzylpiperazine).

158 52. Fluorophenylpiperazine.

159 53. Methylphenylpiperazine.

160 54. Chlorophenylpiperazine.

161 55. Methoxyphenylpiperazine.

162 56. DBZP (1,4-Dibenzylpiperazine).

163 57. TFMPP (Trifluoromethylphenylpiperazine).

164 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4

165 Methylenedioxy-N-methylbutanamine).

166 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

167 60. 5-Hydroxy-N-methyltryptamine.

168 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

169 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

170 63. Methyltryptamine.

171 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

172 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

173 66. Tyramine (4-Hydroxyphenethylamine).

174 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

175 68. DiPT (N,N-Diisopropyltryptamine).

176 69. DPT (N,N-Dipropyltryptamine).

177 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

178 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

179 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).

180 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).

181 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

182 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

183 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

184 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

185 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

186 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

187 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

188 81. Butylone (3,4-Methylenedioxy-alpha

189 methylaminobutyrophenone).

190 82. Ethcathinone.

191 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

192 84. Naphyrone (Naphthylpyrovalerone).

193 85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).

194 86. 3,4-Methylenedioxy-N,N-diethylcathinone.

195 87. 3,4-Methylenedioxy-propiophenone.

196 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.

197 89. 3,4-Methylenedioxy-propiophenone-2-oxime.

198 90. 3,4-Methylenedioxy-N-acetylcathinone.

199 91. 3,4-Methylenedioxy-N-acetylmethcathinone.

200 92. 3,4-Methylenedioxy-N-acetylethcathinone.

201 93. Bromomethcathinone.

202 94. Buphedrone (alpha-Methylamino-butyrophenone).

203 95. Eutylone (3,4-Methylenedioxy-alpha

204 ethylaminobutyrophenone).

205 96. Dimethylcathinone.

206 97. Dimethylmethcathinone.

207 98. Pentylone (3,4-Methylenedioxy-alpha

208 methylaminovalerophenone).

209 99. MDPPP (3,4-Methylenedioxy-alpha

210 pyrrolidinopropiophenone).

211 100. MDPBP (3,4-Methylenedioxy-alpha

212 pyrrolidinobutyrophenone).

213 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

214 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).

215 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP

216 (Benocyclidine).

217 104. F-MABP (Fluoromethylaminobutyrophenone).

218 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).

219 106. Et-PBP (Ethylpyrrolidinobutyrophenone).

220 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

221 108. Me-EABP (Methylethylaminobutyrophenone).

222 109. Etizolam.

223 110. PPP (Pyrrolidinopropiophenone).

224 111. PBP (Pyrrolidinobutyrophenone).

225 112. PVP (Pyrrolidinovalerophenone) or

226 (Pyrrolidinopentiophenone).

227 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).

228 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

229 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

230 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

231 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

232 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

233 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

234 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

235 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan

236 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

237 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

238 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

239 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

240 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

241 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

242 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

243 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

244 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

245 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3

246 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

247 ol).

248 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan

249 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]

250 methanol).

251 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1

252 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene

253 1,4-dione).

254 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).

255 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)

256 undecanamide).

257 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)

258 undecanamide).

259 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2

260 methyloctan-2-yl)phenol).

261 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

262 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).

263 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).

264 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2

265 methoxyphenylacetyl)indole).

266 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4

267 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

268 naphthalenylmethanone).

269 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4

270 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1

271 naphthalenylmethanone).

272 143. Pentedrone (alpha-Methylaminovalerophenone).

273 144. Fluoroamphetamine.

274 145. Fluoromethamphetamine.

275 146. Methoxetamine.

276 147. Methiopropamine.

277 148. Methylbuphedrone (Methyl-alpha

278 methylaminobutyrophenone).

279 149. APB ((2-Aminopropyl)benzofuran).

280 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).

281 151. UR-144 (1-Pentyl-3-(2,2,3,3

282 tetramethylcyclopropanoyl)indole).

283 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3

284 tetramethylcyclopropanoyl)indole).

285 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3

286 tetramethylcyclopropanoyl)indole).

287 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

288 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

289 iodobenzoyl)indole).

290 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3

291 carboxamide).

292 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)

293 cyclohexylcarbamate).

294 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,

295 cyclohexyl ester).

296 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1

297 benzoxazin-4-one).

298 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

299 161. 2C-H (2,5-Dimethoxyphenethylamine).

300 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

301 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

302 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2

303 methoxybenzyl)]phenethylamine).

304 165. MDMA (3,4-Methylenedioxymethamphetamine).

305 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

306 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3

307 carboxylate).

308 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3

309 carboxylate).

310 169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole

311 3-carboxamide).

312 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

313 pentylindazole-3-carboxamide).

314 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

315 (4-fluorobenzyl)indazole-3-carboxamide).

316 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

317 1-pentylindazole-3-carboxamide).

318 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

319 yl)-1-(fluoropentyl)indole-3-carboxamide).

320 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2

321 methoxybenzyl)]phenethylamine).

322 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2

323 methoxybenzyl)]phenethylamine).

324 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

325 (cyclohexylmethyl)indazole-3-carboxamide).

326 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3

327 carboxylate).

328 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

329 3-carboxamide).

330 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

331 (fluoropentyl)indazole-3-carboxamide).

332 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).

333 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl

334 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).

335 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9

336 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

337 hexahydrobenzo[c]chromen-1-ol).

338 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9

339 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a

340 hexahydrobenzo[c]chromen-1-ol).

341 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)

342 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9

343 diol).

344 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6

345 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a

346 tetrahydro-6aH-benzo[c]chromen-1-ol).

347 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl

348 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).

349 187. MAPB ((2-Methylaminopropyl)benzofuran).

350 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).

351 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).

352 190. Synthetic Cannabinoids.—Unless specifically excepted

353 or unless listed in another schedule or contained within a

354 pharmaceutical product approved by the United States Food and

355 Drug Administration, any material, compound, mixture, or

356 preparation that contains any quantity of a synthetic

357 cannabinoid found to be in any of the following chemical class

358 descriptions, or homologues, nitrogen-heterocyclic analogs,

359 isomers (including optical, positional, or geometric), esters,

360 ethers, salts, and salts of homologues, nitrogen-heterocyclic

361 analogs, isomers, esters, or ethers, whenever the existence of

362 such homologues, nitrogen-heterocyclic analogs, isomers, esters,

363 ethers, salts, and salts of isomers, esters, or ethers is

364 possible within the specific chemical class or designation.

365 Since nomenclature of these synthetically produced cannabinoids

366 is not internationally standardized and may continually evolve,

367 these structures or the compounds of these structures shall be

368 included under this subparagraph, regardless of their specific

369 numerical designation of atomic positions covered, if it can be

370 determined through a recognized method of scientific testing or

371 analysis that the substance contains properties that fit within

372 one or more of the following categories:

373 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols

374 naturally contained in a plant of the genus

Cannabis

, the

375 synthetic equivalents of the substances contained in the plant

376 or in the resinous extracts of the genus

Cannabis

, or synthetic

377 substances, derivatives, and their isomers with similar chemical

378 structure and pharmacological activity, including, but not

379 limited to, Delta 9 tetrahydrocannabinols and their optical

380 isomers, Delta 8 tetrahydrocannabinols and their optical

381 isomers, Delta 6a,10a tetrahydrocannabinols and their optical

382 isomers, or any compound containing a tetrahydrobenzo[c]chromene

383 structure with substitution at either or both the 3-position or

384 9-position, with or without substitution at the 1-position with

385 hydroxyl or alkoxy groups, including, but not limited to:

386 (I) Tetrahydrocannabinol.

387 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3

388 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

389 ol).

390 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3

391 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1

392 ol).

393 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3

394 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

395 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan

396 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

397 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan

398 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

399 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3

400 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

401 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)

402 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

403 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl

404 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

405 (X) Parahexyl.

406 b. Naphthoylindoles, Naphthoylindazoles,

407 Naphthoylcarbazoles, Naphthylmethylindoles,

408 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any

409 compound containing a naphthoylindole, naphthoylindazole,

410 naphthoylcarbazole, naphthylmethylindole,

411 naphthylmethylindazole, or naphthylmethylcarbazole structure,

412 with or without substitution on the indole, indazole, or

413 carbazole ring to any extent, whether or not substituted on the

414 naphthyl ring to any extent, including, but not limited to:

415 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

416 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1

417 naphthoyl)indole).

418 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

419 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).

420 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

421 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

422 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

423 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).

424 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).

425 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

426 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

427 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).

428 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

429 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1

430 naphthoyl)indole).

431 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).

432 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

433 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1

434 naphthoyl)indole).

435 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).

436 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

437 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).

438 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).

439 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1

440 naphthylmethyl]indole).

441 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1

442 naphthoyl)indole).

443 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1

444 naphthoyl)indole).

445 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1

446 naphthoyl)indole).

447 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

448 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).

449 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

450 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).

451 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).

452 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1

453 naphthoyl)indole).

454 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1

455 naphthoyl)indole).

456 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1

457 naphthoyl)indole).

458 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1

459 naphthoyl)indole).

460 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1

461 naphthoyl)indole).

462 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).

463 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1

464 naphthoyl)indazole).

465 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1

466 naphthoyl)indole).

467 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1

468 naphthoyl)indole).

469 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).

470 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1

471 naphthoyl)carbazole).

472 c. Naphthoylpyrroles.—Any compound containing a

473 naphthoylpyrrole structure, with or without substitution on the

474 pyrrole ring to any extent, whether or not substituted on the

475 naphthyl ring to any extent, including, but not limited to:

476 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).

477 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).

478 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).

479 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).

480 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).

481 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1

482 naphthoyl)pyrrole).

483 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1

484 naphthoyl)pyrrole).

485 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1

486 naphthoyl)pyrrole).

487 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1

488 naphthoyl)pyrrole).

489 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1

490 naphthoyl)pyrrole).

491 d. Naphthylmethylenindenes.—Any compound containing a

492 naphthylmethylenindene structure, with or without substitution

493 at the 3-position of the indene ring to any extent, whether or

494 not substituted on the naphthyl ring to any extent, including,

495 but not limited to, JWH-176 (3-Pentyl-1

496 (naphthylmethylene)indene).

497 e. Phenylacetylindoles and Phenylacetylindazoles.—Any

498 compound containing a phenylacetylindole or phenylacetylindazole

499 structure, with or without substitution on the indole or

500 indazole ring to any extent, whether or not substituted on the

501 phenyl ring to any extent, including, but not limited to:

502 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).

503 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

504 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

505 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

506 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

507 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

508 (VII) Cannabipiperidiethanone.

509 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2

510 methoxyphenylacetyl)indole).

511 f. Cyclohexylphenols.—Any compound containing a

512 cyclohexylphenol structure, with or without substitution at the

513 5-position of the phenolic ring to any extent, whether or not

514 substituted on the cyclohexyl ring to any extent, including, but

515 not limited to:

516 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2

517 yl)phenol).

518 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)

519 homologue).

520 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2

521 methyloctan-2-yl)phenol).

522 g. Benzoylindoles and Benzoylindazoles.—Any compound

523 containing a benzoylindole or benzoylindazole structure, with or

524 without substitution on the indole or indazole ring to any

525 extent, whether or not substituted on the phenyl ring to any

526 extent, including, but not limited to:

527 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).

528 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

529 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

530 iodo-5-nitrobenzoyl)indole).

531 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4

532 methoxybenzoyl)indole).

533 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2

534 iodobenzoyl)indole).

535 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).

536 (VII) RCS-4 C4 homologue (1-Butyl-3-(4

537 methoxybenzoyl)indole).

538 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo

539 3-(4-methoxybenzoyl)indole).

540 h. Tetramethylcyclopropanoylindoles and

541 Tetramethylcyclopropanoylindazoles.—Any compound containing a

542 tetramethylcyclopropanoylindole or

543 tetramethylcyclopropanoylindazole structure, with or without

544 substitution on the indole or indazole ring to any extent,

545 whether or not substituted on the tetramethylcyclopropyl group

546 to any extent, including, but not limited to:

547 (I) UR-144 (1-Pentyl-3-(2,2,3,3

548 tetramethylcyclopropanoyl)indole).

549 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3

550 tetramethylcyclopropanoyl)indole).

551 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3

552 tetramethylcyclopropanoyl)indole).

553 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3

554 tetramethylcyclopropanoyl)indole).

555 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3

556 tetramethylcyclopropanoyl)indole).

557 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3

558 tetramethylcyclopropanoyl)indole).

559 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3

560 tetramethylcyclopropanoyl)indole).

561 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3

562 tetramethylcyclopropanoyl)indazole).

563 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3

564 tetramethylcyclopropanoyl)indole).

565 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3

566 tetramethylcyclopropanoyl)indole).

567 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole

568 carboxamides, and Adamantylindazole carboxamides.—Any compound

569 containing an adamantoyl indole, adamantoyl indazole, adamantyl

570 indole carboxamide, or adamantyl indazole carboxamide structure,

571 with or without substitution on the indole or indazole ring to

572 any extent, whether or not substituted on the adamantyl ring to

573 any extent, including, but not limited to:

574 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

575 (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole

576 3-carboxamide).

577 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3

578 carboxamide).

579 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1

580 adamantoyl)indole).

581 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).

582 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).

583 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1

584 adamantoyl)indole).

585 j. Quinolinylindolecarboxylates,

586 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,

587 and Quinolinylindazolecarboxamides.—Any compound containing a

588 quinolinylindole carboxylate, quinolinylindazole carboxylate,

589 isoquinolinylindole carboxylate, isoquinolinylindazole

590 carboxylate, quinolinylindole carboxamide, quinolinylindazole

591 carboxamide, isoquinolinylindole carboxamide, or

592 isoquinolinylindazole carboxamide structure, with or without

593 substitution on the indole or indazole ring to any extent,

594 whether or not substituted on the quinoline or isoquinoline ring

595 to any extent, including, but not limited to:

596 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

597 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3

598 carboxylate).

599 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3

600 carboxylate).

601 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3

602 carboxylate).

603 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).

604 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole

605 3-carboxylate).

606 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole

607 3-carboxylate).

608 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).

609 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3

610 carboxamide).

611 k. Naphthylindolecarboxylates and

612 Naphthylindazolecarboxylates.—Any compound containing a

613 naphthylindole carboxylate or naphthylindazole carboxylate

614 structure, with or without substitution on the indole or

615 indazole ring to any extent, whether or not substituted on the

616 naphthyl ring to any extent, including, but not limited to:

617 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3

618 carboxylate).

619 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3

620 carboxylate).

621 (III) Fluoro SDB-005 (1-Naphthalenyl 1

622 (fluoropentyl)indazole-3-carboxylate).

623 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3

624 carboxylate).

625 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3

626 carboxylate).

627 l. Naphthylindole carboxamides and Naphthylindazole

628 carboxamides.—Any compound containing a naphthylindole

629 carboxamide or naphthylindazole carboxamide structure, with or

630 without substitution on the indole or indazole ring to any

631 extent, whether or not substituted on the naphthyl ring to any

632 extent, including, but not limited to:

633 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).

634 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole

635 3-carboxamide).

636 (III) Chloro-NNEI (N-Naphthalen-1-yl 1

637 (chloropentyl)indole-3-carboxamide).

638 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3

639 carboxamide).

640 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1

641 (fluoropentyl)indazole-3-carboxamide).

642 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl

643 indazole carboxamides, Alkylcarbonyl indole carboxylates, and

644 Alkylcarbonyl indazole carboxylates.—Any compound containing an

645 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,

646 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3

647 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an

648 indole carboxamide, indazole carboxamide, indole carboxylate, or

649 indazole carboxylate, with or without substitution on the indole

650 or indazole ring to any extent, whether or not substituted on

651 the alkylcarbonyl group to any extent, including, but not

652 limited to:

653 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1

654 pentylindole-3-carboxamide).

655 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

656 yl)-1-(fluoropentyl)indole-3-carboxamide).

657 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

658 (fluoropentyl)indole-3-carboxamide).

659 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

660 pentylindazole-3-carboxamide).

661 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)

662 1-(fluoropentyl)indazole-3-carboxamide).

663 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)

664 1-pentylindazole-3-carboxamide).

665 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1

666 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

667 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

668 (4-fluorobenzyl)indazole-3-carboxamide).

669 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

670 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

671 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1

672 (cyclohexylmethyl)indazole-3-carboxamide).

673 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

674 (cyclohexylmethyl)indazole-3-carboxamide).

675 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2

676 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

677 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

678 pentylindazole-3-carboxamide).

679 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1

680 (fluoropentyl)indazole-3-carboxamide).

681 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4

682 fluorobenzyl)indazole-3-carboxamide).

683 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

684 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

685 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

686 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

687 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

688 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).

689 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

690 fluoropentyl)indole-3-carboxamide).

691 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5

692 fluoropentyl)indazole-3-carboxamide).

693 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1

694 (cyclohexylmethyl)indazole-3-carboxamide).

695 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4

696 fluorobenzyl)indazole-3-carboxamide).

697 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan

698 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).

699 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.

700 Any compound containing a N-(2-phenylpropan-2-yl) indole

701 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide

702 structure, with or without substitution on the indole or

703 indazole ring to any extent, whether or not substituted on the

704 phenyl ring of the cumyl group to any extent, including, but not

705 limited to:

706 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3

707 carboxamide).

708 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1

709 (fluoropentyl)indole-3-carboxamide).

710 o. Other Synthetic Cannabinoids.—Any material, compound,

711 mixture, or preparation that contains any quantity of a

712 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:

713 (I) With or without modification or replacement of a

714 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage

715 between either two core rings, or linkage between a core ring

716 and group structure, with or without the addition of a carbon or

717 replacement of a carbon;

718 (II) With or without replacement of a core ring or group

719 structure, whether or not substituted on the ring or group

720 structures to any extent; and

721 (III) Is a cannabinoid receptor agonist, unless

722 specifically excepted or unless listed in another schedule or

723 contained within a pharmaceutical product approved by the United

724 States Food and Drug Administration.

725 191. Substituted Cathinones.—Unless specifically excepted,

726 listed in another schedule, or contained within a pharmaceutical

727 product approved by the United States Food and Drug

728 Administration, any material, compound, mixture, or preparation,

729 including its salts, isomers, esters, or ethers, and salts of

730 isomers, esters, or ethers, whenever the existence of such salts

731 is possible within any of the following specific chemical

732 designations:

733 a. Any compound containing a 2-amino-1-phenyl-1-propanone

734 structure;

735 b. Any compound containing a 2-amino-1-naphthyl-1-propanone

736 structure; or

737 c. Any compound containing a 2-amino-1-thiophenyl-1

738 propanone structure,

739

740 whether or not the compound is further modified:

741 (I) With or without substitution on the ring system to any

742 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,

743 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused

744 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide

745 substituents;

746 (II) With or without substitution at the 3-propanone

747 position with an alkyl substituent or removal of the methyl

748 group at the 3-propanone position;

749 (III) With or without substitution at the 2-amino nitrogen

750 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or

751 not further substituted in the ring system; or

752 (IV) With or without inclusion of the 2-amino nitrogen atom

753 in a cyclic structure, including, but not limited to:

754 (A) Methcathinone.

755 (B) Ethcathinone.

756 (C) Methylone (3,4-Methylenedioxymethcathinone).

757 (D) 2,3-Methylenedioxymethcathinone.

758 (E) MDPV (3,4-Methylenedioxypyrovalerone).

759 (F) Methylmethcathinone.

760 (G) Methoxymethcathinone.

761 (H) Fluoromethcathinone.

762 (I) Methylethcathinone.

763 (J) Butylone (3,4-Methylenedioxy-alpha

764 methylaminobutyrophenone).

765 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

766 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).

767 (M) Naphyrone (Naphthylpyrovalerone).

768 (N) Bromomethcathinone.

769 (O) Buphedrone (alpha-Methylaminobutyrophenone).

770 (P) Eutylone (3,4-Methylenedioxy-alpha

771 ethylaminobutyrophenone).

772 (Q) Dimethylcathinone.

773 (R) Dimethylmethcathinone.

774 (S) Pentylone (3,4-Methylenedioxy-alpha

775 methylaminovalerophenone).

776 (T) Pentedrone (alpha-Methylaminovalerophenone).

777 (U) MDPPP (3,4-Methylenedioxy-alpha

778 pyrrolidinopropiophenone).

779 (V) MDPBP (3,4-Methylenedioxy-alpha

780 pyrrolidinobutyrophenone).

781 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).

782 (X) PPP (Pyrrolidinopropiophenone).

783 (Y) PVP (Pyrrolidinovalerophenone) or

784 (Pyrrolidinopentiophenone).

785 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

786 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).

787 (BB) F-MABP (Fluoromethylaminobutyrophenone).

788 (CC) Me-EABP (Methylethylaminobutyrophenone).

789 (DD) PBP (Pyrrolidinobutyrophenone).

790 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).

791 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).

792 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

793 (HH) Dimethylone (3,4-Methylenedioxy-N,N

794 dimethylcathinone).

795 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.

796 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.

797 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.

798 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.

799 (MM) Methylbuphedrone (Methyl-alpha

800 methylaminobutyrophenone).

801 (NN) Methyl-alpha-methylaminohexanophenone.

802 (OO) N-Ethyl-N-methylcathinone.

803 (PP) PHP (Pyrrolidinohexanophenone).

804 (QQ) PV8 (Pyrrolidinoheptanophenone).

805 (RR) Chloromethcathinone.

806 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.

807 192. Substituted Phenethylamines.—Unless specifically

808 excepted or unless listed in another schedule, or contained

809 within a pharmaceutical product approved by the United States

810 Food and Drug Administration, any material, compound, mixture,

811 or preparation, including its salts, isomers, esters, or ethers,

812 and salts of isomers, esters, or ethers, whenever the existence

813 of such salts is possible within any of the following specific

814 chemical designations, any compound containing a phenethylamine

815 structure, without a beta-keto group, and without a benzyl group

816 attached to the amine group, whether or not the compound is

817 further modified with or without substitution on the phenyl ring

818 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,

819 halide, fused alkylenedioxy, fused furan, fused benzofuran,

820 fused dihydrofuran, or fused tetrahydropyran substituents,

821 whether or not further substituted on a ring to any extent, with

822 or without substitution at the alpha or beta position by any

823 alkyl substituent, with or without substitution at the nitrogen

824 atom, and with or without inclusion of the 2-amino nitrogen atom

825 in a cyclic structure, including, but not limited to:

826 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

827 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

828 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

829 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

830 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

831 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

832 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

833 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

834 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

835 j. 2C-H (2,5-Dimethoxyphenethylamine).

836 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

837 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

838 m. MDMA (3,4-Methylenedioxymethamphetamine).

839 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4

840 Methylenedioxy-N-methylbutanamine).

841 o. MDA (3,4-Methylenedioxyamphetamine).

842 p. 2,5-Dimethoxyamphetamine.

843 q. Fluoroamphetamine.

844 r. Fluoromethamphetamine.

845 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

846 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).

847 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).

848 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).

849 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).

850 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).

851 y. PMA (4-Methoxyamphetamine).

852 z. N-Ethylamphetamine.

853 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.

854 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.

855 cc. PMMA (4-Methoxymethamphetamine).

856 dd. N,N-Dimethylamphetamine.

857 ee. 3,4,5-Trimethoxyamphetamine.

858 ff. 4-APB (4-(2-Aminopropyl)benzofuran).

859 gg. 5-APB (5-(2-Aminopropyl)benzofuran).

860 hh. 6-APB (6-(2-Aminopropyl)benzofuran).

861 ii. 7-APB (7-(2-Aminopropyl)benzofuran).

862 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).

863 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).

864 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).

865 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).

866 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).

867 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).

868 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).

869 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).

870 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).

871 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3

872 dihydrobenzofuran),

873

874 which does not include phenethylamine, mescaline as described in

875 subparagraph 20., substituted cathinones as described in

876 subparagraph 191., N-Benzyl phenethylamine compounds as

877 described in subparagraph 193., or methamphetamine as described

878 in subparagraph (2)(c)5.

879 193. N-Benzyl Phenethylamine Compounds.—Unless specifically

880 excepted or unless listed in another schedule, or contained

881 within a pharmaceutical product approved by the United States

882 Food and Drug Administration, any material, compound, mixture,

883 or preparation, including its salts, isomers, esters, or ethers,

884 and salts of isomers, esters, or ethers, whenever the existence

885 of such salts is possible within any of the following specific

886 chemical designations, any compound containing a phenethylamine

887 structure without a beta-keto group, with substitution on the

888 nitrogen atom of the amino group with a benzyl substituent, with

889 or without substitution on the phenyl or benzyl ring to any

890 extent with alkyl, alkoxy, thio, alkylthio, halide, fused

891 alkylenedioxy, fused furan, fused benzofuran, or fused

892 tetrahydropyran substituents, whether or not further substituted

893 on a ring to any extent, with or without substitution at the

894 alpha position by any alkyl substituent, including, but not

895 limited to:

896 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2

897 methoxybenzyl)]phenethylamine).

898 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2

899 hydroxybenzyl)]phenethylamine).

900 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2

901 fluorobenzyl)]phenethylamine).

902 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3

903 methylenedioxybenzyl)]phenethylamine).

904 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2

905 methoxybenzyl)]phenethylamine).

906 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2

907 hydroxybenzyl)]phenethylamine).

908 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2

909 fluorobenzyl)]phenethylamine).

910 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3

911 methylenedioxybenzyl)]phenethylamine).

912 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2

913 methoxybenzyl)]phenethylamine).

914 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2

915 methoxybenzyl)]phenethylamine).

916 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2

917 methoxybenzyl)]phenethylamine).

918 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2

919 methoxybenzyl)]phenethylamine).

920 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2

921 hydroxybenzyl)]phenethylamine).

922 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2

923 fluorobenzyl)]phenethylamine).

924 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3

925 methylenedioxybenzyl)]phenethylamine).

926 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2

927 methoxybenzyl)]phenethylamine).

928 q. 25H-NBOH (2,5-Dimethoxy-[N-(2

929 hydroxybenzyl)]phenethylamine).

930 r. 25H-NBF (2,5-Dimethoxy-[N-(2

931 fluorobenzyl)]phenethylamine).

932 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2

933 methoxybenzyl)]phenethylamine),

934

935 which does not include substituted cathinones as described in

936 subparagraph 191.

937 194. Substituted Tryptamines.—Unless specifically excepted

938 or unless listed in another schedule, or contained within a

939 pharmaceutical product approved by the United States Food and

940 Drug Administration, any material, compound, mixture, or

941 preparation containing a 2-(1H-indol-3-yl)ethanamine, for

942 example tryptamine, structure with or without mono- or di

943 substitution of the amine nitrogen with alkyl or alkenyl groups,

944 or by inclusion of the amino nitrogen atom in a cyclic

945 structure, whether or not substituted at the alpha position with

946 an alkyl group, whether or not substituted on the indole ring to

947 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy

948 groups, including, but not limited to:

949 a. Alpha-Ethyltryptamine.

950 b. Bufotenine.

951 c. DET (Diethyltryptamine).

952 d. DMT (Dimethyltryptamine).

953 e. MET (N-Methyl-N-ethyltryptamine).

954 f. DALT (N,N-Diallyltryptamine).

955 g. EiPT (N-Ethyl-N-isopropyltryptamine).

956 h. MiPT (N-Methyl-N-isopropyltryptamine).

957 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

958 j. 5-Hydroxy-N-methyltryptamine.

959 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

960 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

961 m. Methyltryptamine.

962 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

963 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

964 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

965 q. DiPT (N,N-Diisopropyltryptamine).

966 r. DPT (N,N-Dipropyltryptamine).

967 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

968 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

969 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).

970 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).

971 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).

972 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).

973 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N

974 isopropyltryptamine).

975 z. Methyl-alpha-ethyltryptamine.

976 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),

977

978 which does not include tryptamine, psilocyn as described in

979 subparagraph 34., or psilocybin as described in subparagraph 33.

980 195. Substituted Phenylcyclohexylamines.—Unless

981 specifically excepted or unless listed in another schedule, or

982 contained within a pharmaceutical product approved by the United

983 States Food and Drug Administration, any material, compound,

984 mixture, or preparation containing a phenylcyclohexylamine

985 structure, with or without any substitution on the phenyl ring,

986 any substitution on the cyclohexyl ring, any replacement of the

987 phenyl ring with a thiophenyl or benzothiophenyl ring, with or

988 without substitution on the amine with alkyl, dialkyl, or alkoxy

989 substituents, inclusion of the nitrogen in a cyclic structure,

990 or any combination of the above, including, but not limited to:

991 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP

992 (Benocyclidine).

993 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog

994 of phencyclidine).

995 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine

996 analog of phencyclidine).

997 d. PCPr (Phenylcyclohexylpropylamine).

998 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene

999 analog of phencyclidine).

1000 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).

1001 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).

1002 h. Methoxetamine.

1003 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).

1004 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).

1005 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).

1006 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).

1007 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).

1008 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).

1009 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).

1010 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).

1011 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).

1012 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).

1013 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2

1014 piperidinylidene]-benzenesulfonamide.

1015 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2

1016 piperidinylidene]-benzenesulfonamide.

1017 198. AH-7921, 3,4-dichloro-N-[[1

1018 (dimethylamino)cyclohexyl]methyl]-benzamide.

1019 199. U47700, trans-3,4-dichloro-N-[2

1020 (dimethylamino)cyclohexyl]-N-methyl-benzamide.

1021 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,

1022 dihydrochloride.

1023 Section 4. Paragraph (i) of subsection (1) of section

1024 893.13, Florida Statutes, is amended to read:

1025 893.13 Prohibited acts; penalties.—

1026 (1)

1027 (i) Except as authorized by this chapter, a person commits

1028 a felony of the first degree, punishable as provided in s.

1029 775.082, s. 775.083, or s. 775.084, and must be sentenced to a

1030 mandatory minimum term of imprisonment of 3 years, if:

1031 1. The person sells, manufactures, or delivers, or

1032 possesses with intent to sell, manufacture, or deliver, any of

1033 the following:

1034 a. Alfentanil, as described in s. 893.03(2)(b)1.;

1035 b. Carfentanil, as described in s. 893.03(2)(b)6.;

1036 c. Fentanyl, as described in s. 893.03(2)(b)9.;

1037 d. Sufentanil, as described in s. 893.03(2)(b)30.;

1038 e. A fentanyl derivative, as described in s.

1039 893.03(1)(a)63.;

1040

f.

Xylazine, as described in s. 893.03(1)(c)37.;

1041

g.

f.

A controlled substance analog, as described in s.

1042 893.0356, of any substance described in

sub-subparagraphs a.-f.

1043

sub-subparagraphs a.-e.

; or

1044

h.

g.

A mixture containing any substance described in

sub

1045

subparagraphs a.-g.

sub-subparagraphs a.-f.

; and

1046 2. The substance or mixture listed in subparagraph 1. is in

1047 a form that resembles, or is mixed, granulated, absorbed, spray

1048 dried, or aerosolized as or onto, coated on, in whole or in

1049 part, or solubilized with or into, a product, when such product

1050 or its packaging further has at least one of the following

1051 attributes:

1052 a. Resembles the trade dress of a branded food product,

1053 consumer food product, or logo food product;

1054 b. Incorporates an actual or fake registered copyright,

1055 service mark, or trademark;

1056 c. Resembles candy, cereal, a gummy, a vitamin, or a

1057 chewable product, such as a gum or gelatin-based product; or

1058 d. Contains a cartoon character imprint.

1059 Section 5. Paragraph (c) of subsection (1) of section

1060 893.135, Florida Statutes, is amended to read:

1061 893.135 Trafficking; mandatory sentences; suspension or

1062 reduction of sentences; conspiracy to engage in trafficking.—

1063 (1) Except as authorized in this chapter or in chapter 499

1064 and notwithstanding the provisions of s. 893.13:

1065 (c)1. A person who knowingly sells, purchases,

1066 manufactures, delivers, or brings into this state, or who is

1067 knowingly in actual or constructive possession of, 4 grams or

1068 more of any morphine, opium, hydromorphone, or any salt,

1069 derivative, isomer, or salt of an isomer thereof, including

1070 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or

1071 (3)(c)4., or 4 grams or more of any mixture containing any such

1072 substance, but less than 30 kilograms of such substance or

1073 mixture, commits a felony of the first degree, which felony

1074 shall be known as “trafficking in illegal drugs,” punishable as

1075 provided in s. 775.082, s. 775.083, or s. 775.084. If the

1076 quantity involved:

1077 a. Is 4 grams or more, but less than 14 grams, such person

1078 shall be sentenced to a mandatory minimum term of imprisonment

1079 of 3 years and shall be ordered to pay a fine of $50,000.

1080 b. Is 14 grams or more, but less than 28 grams, such person

1081 shall be sentenced to a mandatory minimum term of imprisonment

1082 of 15 years and shall be ordered to pay a fine of $100,000.

1083 c. Is 28 grams or more, but less than 30 kilograms, such

1084 person shall be sentenced to a mandatory minimum term of

1085 imprisonment of 25 years and shall be ordered to pay a fine of

1086 $500,000.

1087 2. A person who knowingly sells, purchases, manufactures,

1088 delivers, or brings into this state, or who is knowingly in

1089 actual or constructive possession of, 28 grams or more of

1090 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as

1091 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28

1092 grams or more of any mixture containing any such substance,

1093 commits a felony of the first degree, which felony shall be

1094 known as “trafficking in hydrocodone,” punishable as provided in

1095 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:

1096 a. Is 28 grams or more, but less than 50 grams, such person

1097 shall be sentenced to a mandatory minimum term of imprisonment

1098 of 3 years and shall be ordered to pay a fine of $50,000.

1099 b. Is 50 grams or more, but less than 100 grams, such

1100 person shall be sentenced to a mandatory minimum term of

1101 imprisonment of 7 years and shall be ordered to pay a fine of

1102 $100,000.

1103 c. Is 100 grams or more, but less than 300 grams, such

1104 person shall be sentenced to a mandatory minimum term of

1105 imprisonment of 15 years and shall be ordered to pay a fine of

1106 $500,000.

1107 d. Is 300 grams or more, but less than 30 kilograms, such

1108 person shall be sentenced to a mandatory minimum term of

1109 imprisonment of 25 years and shall be ordered to pay a fine of

1110 $750,000.

1111 3. A person who knowingly sells, purchases, manufactures,

1112 delivers, or brings into this state, or who is knowingly in

1113 actual or constructive possession of, 7 grams or more of

1114 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt

1115 thereof, or 7 grams or more of any mixture containing any such

1116 substance, commits a felony of the first degree, which felony

1117 shall be known as “trafficking in oxycodone,” punishable as

1118 provided in s. 775.082, s. 775.083, or s. 775.084. If the

1119 quantity involved:

1120 a. Is 7 grams or more, but less than 14 grams, such person

1121 shall be sentenced to a mandatory minimum term of imprisonment

1122 of 3 years and shall be ordered to pay a fine of $50,000.

1123 b. Is 14 grams or more, but less than 25 grams, such person

1124 shall be sentenced to a mandatory minimum term of imprisonment

1125 of 7 years and shall be ordered to pay a fine of $100,000.

1126 c. Is 25 grams or more, but less than 100 grams, such

1127 person shall be sentenced to a mandatory minimum term of

1128 imprisonment of 15 years and shall be ordered to pay a fine of

1129 $500,000.

1130 d. Is 100 grams or more, but less than 30 kilograms, such

1131 person shall be sentenced to a mandatory minimum term of

1132 imprisonment of 25 years and shall be ordered to pay a fine of

1133 $750,000.

1134 4.a. A person who knowingly sells, purchases, manufactures,

1135 delivers, or brings into this state, or who is knowingly in

1136 actual or constructive possession of, 4 grams or more of:

1137 (I) Alfentanil, as described in s. 893.03(2)(b)1.;

1138 (II) Carfentanil, as described in s. 893.03(2)(b)6.;

1139 (III) Fentanyl, as described in s. 893.03(2)(b)9.;

1140 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;

1141 (V) A fentanyl derivative, as described in s.

1142 893.03(1)(a)63.;

1143 (VI) A controlled substance analog, as described in s.

1144 893.0356, of any substance described in sub-sub-subparagraphs

1145 (I)-(V); or

1146 (VII) A mixture containing any substance described in sub

1147 sub-subparagraphs (I)-(VI),

1148

1149 commits a felony of the first degree, which felony shall be

1150 known as “trafficking in dangerous fentanyl or fentanyl

1151 analogues,” punishable as provided in s. 775.082, s. 775.083, or

1152 s. 775.084.

1153 b. If the quantity involved under sub-subparagraph a.:

1154 (I) Is 4 grams or more, but less than 14 grams, such person

1155 shall be sentenced to a mandatory minimum term of imprisonment

1156 of 7 years

,

and shall be ordered to pay a fine of $50,000.

1157 (II) Is 14 grams or more, but less than 28 grams, such

1158 person shall be sentenced to a mandatory minimum term of

1159 imprisonment of 20 years

,

and shall be ordered to pay a fine of

1160 $100,000.

1161 (III) Is 28 grams or more, such person shall be sentenced

1162 to a mandatory minimum term of imprisonment of 25 years

,

and

1163 shall be ordered to pay a fine of $500,000.

1164 c. A person 18 years of age or older who violates sub

1165 subparagraph a. by knowingly selling or delivering to a minor at

1166 least 4 grams of a substance or mixture listed in sub

1167 subparagraph a. shall be sentenced to a mandatory minimum term

1168 of not less than 25 years and not exceeding life imprisonment,

1169 and shall be ordered to pay a fine of $1 million if the

1170 substance or mixture listed in sub-subparagraph a. is in a form

1171 that resembles, or is mixed, granulated, absorbed, spray-dried,

1172 or aerosolized as or onto, coated on, in whole or in part, or

1173 solubilized with or into, a product, when such product or its

1174 packaging further has at least one of the following attributes:

1175 (I) Resembles the trade dress of a branded food product,

1176 consumer food product, or logo food product;

1177 (II) Incorporates an actual or fake registered copyright,

1178 service mark, or trademark;

1179 (III) Resembles candy, cereal, a gummy, a vitamin, or a

1180 chewable product, such as a gum or gelatin-based product; or

1181 (IV) Contains a cartoon character imprint.

1182 5. A person who knowingly sells, purchases, manufactures,

1183 delivers, or brings into this state, or who is knowingly in

1184 actual or constructive possession of, 30 kilograms or more of

1185 any morphine, opium, oxycodone, hydrocodone, codeine,

1186 hydromorphone, or any salt, derivative, isomer, or salt of an

1187 isomer thereof, including heroin, as described in s.

1188 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or

1189 more of any mixture containing any such substance, commits the

1190 first degree felony of trafficking in illegal drugs. A person

1191 who has been convicted of the first degree felony of trafficking

1192 in illegal drugs under this subparagraph shall be punished by

1193 life imprisonment and is ineligible for any form of

1194 discretionary early release except pardon or executive clemency

1195 or conditional medical release under s. 947.149. However, if the

1196 court determines that, in addition to committing any act

1197 specified in this paragraph:

1198 a. The person intentionally killed an individual or

1199 counseled, commanded, induced, procured, or caused the

1200 intentional killing of an individual and such killing was the

1201 result; or

1202 b. The person’s conduct in committing that act led to a

1203 natural, though not inevitable, lethal result,

1204

1205 such person commits the capital felony of trafficking in illegal

1206 drugs, punishable as provided in ss. 775.082 and 921.142. A

1207 person sentenced for a capital felony under this paragraph shall

1208 also be sentenced to pay the maximum fine provided under

1209 subparagraph 1.

1210 6. A person who knowingly brings into this state 60

1211 kilograms or more of any morphine, opium, oxycodone,

1212 hydrocodone, codeine, hydromorphone, or any salt, derivative,

1213 isomer, or salt of an isomer thereof, including heroin, as

1214 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or

1215 60 kilograms or more of any mixture containing any such

1216 substance, and who knows that the probable result of such

1217 importation would be the death of a person, commits capital

1218 importation of illegal drugs, a capital felony punishable as

1219 provided in ss. 775.082 and 921.142. A person sentenced for a

1220 capital felony under this paragraph shall also be sentenced to

1221 pay the maximum fine provided under subparagraph 1.

1222

7.

A person who knowingly sells, purchases, manufactures,

1223

delivers, or brings into this state, or who is knowingly in

1224

actual or constructive possession of, 28 grams or more of

1225

xylazine, as described in s. 893.03(1)(c)37., or any salt

1226

thereof, or 28 grams or more of any mixture containing any such

1227

substance, commits a felony of the first degree, which felony

1228

shall be known as “trafficking in xylazine,” punishable as

1229

provided in s. 775.082, s. 775.083, or s. 775.084. If the

1230

quantity involved:

1231

a.

Is 28 grams or more, but less than 100 grams, such

1232

person shall be sentenced to a mandatory minimum term of

1233

imprisonment of 3 years and shall be ordered to pay a fine of

1234

$50,000.

1235

b.

Is 100 grams or more, but less than 200 grams, such

1236

person shall be sentenced to a mandatory minimum term of

1237

imprisonment of 7 years and shall be ordered to pay a fine of

1238

$100,000.

1239

c.

Is 200 grams or more, such person shall be sentenced to

1240

a mandatory minimum term of imprisonment of 25 years and shall

1241

be ordered to pay a fine of $500,000.

1242 Section 6. Except as otherwise expressly provided in this

1243 act and except for this section, which shall take effect upon

1244 this act becoming a law, this act shall take effect October 1,

1245 2026.

Volver al texto completo